Who Owns Compass Therapeutics Stock?
NASDAQ: CMPXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 85.75%
- Held by insiders
- 12.47%
- Institutional holders
- 218
- Institutions 85.7%
- Insiders 12.5%
- Public and other 1.8%
Who owns Compass Therapeutics stock?
Institutional investors own about 85.7% of Compass Therapeutics's shares, spread across 218 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 12.47% of CMPX.
The largest institutional holders are Tang Capital Management, LLC (34.52%), Orbimed Advisors LLC. (29.20%) and Montanova Capital LLC (27.49%). Together, the top 10 institutions control 185.1% of shares outstanding. In their latest filings, 4 of the top 10 institutions increased their CMPX positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of CMPX
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Tang Capital Management, LLC | 17.99M | 34.52% | 0.0% |
| Orbimed Advisors LLC. | 15.22M | 29.20% | 0.0% |
| Montanova Capital LLC | 14.33M | 27.49% | +1.6% |
| Blackrock Inc. | 11.39M | 21.86% | +1.0% |
| Enavate Sciences Gp, LLC | 7.79M | 14.94% | 0.0% |
| State Street Corporation | 7.74M | 14.85% | -22.3% |
| Palo Alto Investors Lp | 7.15M | 13.71% | +22.6% |
| Vanguard Capital Management LLC | 5.99M | 11.50% | -2.0% |
| Millennium Management Llc | 4.69M | 8.99% | -0.6% |
| Qube Research & Technologies Ltd | 4.17M | 8.00% | +13.1% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of CMPX
| Fund | Shares | % Held |
|---|---|---|
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 4.81M | 9.22% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 4.19M | 8.04% |
| iShares Trust-iShares Russell 2000 ETF | 3.48M | 6.67% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.79M | 3.44% |
| Fidelity Commonwealth Trust II-Fidelity Enhanced Small Cap Core ETF | 1.61M | 3.10% |
| iShares Trust-iShares Russell 2000 Value ETF | 1.22M | 2.34% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 1.06M | 2.03% |
| Vanguard Explorer Fund | 962.80K | 1.85% |
| VANGUARD VARIABLE INSURANCE FUNDS-Small Company Growth Portfolio | 775.00K | 1.49% |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund | 752.67K | 1.44% |
Frequently asked questions
Who is the largest shareholder of Compass Therapeutics?
Tang Capital Management, LLC is the largest institutional shareholder of CMPX, owning 34.52% of shares outstanding (17.99M shares) as of its latest 13F filing.
What percentage of Compass Therapeutics is owned by institutions?
Institutions own about 85.7% of CMPX shares and 98.0% of the public float.
How much of Compass Therapeutics do insiders own?
Insiders, such as officers and directors, own about 12.47% of CMPX shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.